Aesica Pharmaceuticals, a pharmaceutical contract development and manufacturing organization, announced on April 5, 2016 it has doubled its development capacity with the addition of the ability to manufacture multiple drug products up to Phase III clinical trials at its Queenborough facility.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.